Literature DB >> 10049296

Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis.

E J Goldstein1, D M Citron, C V Merriam.   

Abstract

By an agar dilution method, the antimicrobial susceptibilities of antral sinus puncture isolates were studied. Pneumococci were generally susceptible to amoxicillin, azithromycin, and clarithromycin, but 17% of pneumococcal isolates were resistant to cefuroxime. Haemophilus influenzae isolates were resistant to amoxicillin and clarithromycin. beta-Lactamase production occurred in 69% of Prevotella species. One-third of Peptostreptococcus magnus isolates were resistant to azithromycin and clarithromycin. Cefuroxime had limited activity against Prevotella species and P. magnus. Levofloxacin was active against most isolates except peptostreptococci. Amoxicillin-clavulanate was active against all isolates, with the MIC at which 90% of the isolates were inhibited being < or = 1 microgram/ml.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049296      PMCID: PMC89189     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Microbiology of the transition from acute to chronic maxillary sinusitis.

Authors:  I Brook; E H Frazier; P A Foote
Journal:  J Med Microbiol       Date:  1996-11       Impact factor: 2.472

2.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A Brueggemann; H P Holley; A M Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.

Authors:  S Hunt Gerardo; D M Citron; M C Claros; E J Goldstein
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

4.  Bacteriology and beta-lactamase activity in acute and chronic maxillary sinusitis.

Authors:  I Brook; P Yocum; E H Frazier
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1996-04

5.  Anaerobic infection of the paranasal sinuses.

Authors:  J Frederick; A I Braude
Journal:  N Engl J Med       Date:  1974-01-17       Impact factor: 91.245

6.  Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.

Authors:  C Thornsberry; P Ogilvie; J Kahn; Y Mauriz
Journal:  Diagn Microbiol Infect Dis       Date:  1997-12       Impact factor: 2.803

Review 7.  Gram-positive anaerobic cocci.

Authors:  D A Murdoch
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 8.  Antimicrobial resistance in anaerobes.

Authors:  B A Rasmussen; K Bush; F P Tally
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

9.  Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin.

Authors:  E J Goldstein; V L Sutter; Y Y Kwok; R P Lewis; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

10.  Effect of carbon dioxide on erythromycin.

Authors:  E J Goldstein; V L Sutter
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

  10 in total
  5 in total

1.  In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

Authors:  E J Goldstein; G Conrads; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi Warren; Kerin L Tyrrel; Helen Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

4.  D-LL-31 enhances biofilm-eradicating effect of currently used antibiotics for chronic rhinosinusitis and its immunomodulatory activity on human lung epithelial cells.

Authors:  Saharut Wongkaewkhiaw; Suwimol Taweechaisupapong; Sanguansak Thanaviratananich; Jan G M Bolscher; Kamran Nazmi; Chitchanok Anutrakunchai; Sorujsiri Chareonsudjai; Sakawrat Kanthawong
Journal:  PLoS One       Date:  2020-12-16       Impact factor: 3.240

5.  A European perspective on topical ophthalmic antibiotics: current and evolving options.

Authors:  D Bremond-Gignac; F Chiambaretta; S Milazzo
Journal:  Ophthalmol Eye Dis       Date:  2011-10-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.